Amgen's postmenopausal osteoporosis drug gets FDA greenlight
The U.S. Food and Drug Administration said on Tuesday it had approved Amgen Inc's osteoporosis treatment for postmenopausal women who are at high risk of fracture.
from Reuters: Health News https://reut.rs/2KkBI45
http://bit.ly/2zwRqiM